Neil Dahiya

Neo Medical SA, a pioneering Swiss firm in spinal surgery technology, has proudly announced that its full suite of products has gained approval under the European Union’s updated Medical Device Regulation (MDR) EU 2017/745. This accomplishment underscores the company’s adherence […]

Renalys Pharma, Inc., a biopharmaceutical company advancing in late-stage clinical trials, has announced that its drug sparsentan, acquired from Travere Therapeutics, Inc. (Travere), currently undergoing phase III studies in Japan, has been granted Orphan Drug Designation by Japan’s Ministry of

Everest Medicines, a prominent biopharmaceutical firm dedicated to pioneering drug discovery, clinical progress, production, and bringing novel treatments to market, announced the Hong Kong Special Administrative Region’s Department of Health has accepted their New Drug Application (NDA) for Velsipity (etrasimod).

Mallinckrodt plc, renowned for its specialty pharmaceutical solutions, has officially concluded the sale of its Therakos unit to CVC Capital Partners Fund IX in a deal valued at $925 million, subject to standard adjustments. Siggi Olafsson, serving as president and

The Suvarna Karnataka Chemists and Distributors Association (SKCDA) has called upon the state’s administration to retract the suspension of the Karnataka drugs controller, Dr. Umesh S. This suspension was declared by Chief Minister Siddaramaiah on November 30, who also insisted

Dr. H.G. Koshia, Commissioner of Gujarat FDCA, has announced that Indian Pharma MSMEs are adopting the Revised Schedule M guidelines with greater enthusiasm. They are preparing to develop a comprehensive Pharmaceutical Quality System (PQS), integrate Quality Risk Management (QRM), conduct

The All India Public and Private Sector Pharmacists Association (AIPPSPA), a national collective of pharmacist organizations, is gearing up to hold a meeting with representatives from across the nation in Kerala on December 7 and 8. This gathering is organized

Following a directive from the Department of Pharmaceuticals (DoP) in October, the National Pharmaceutical Pricing Authority (NPPA) has updated the draft pricing document concerning the retail price of Glenmark Pharmaceuticals’ cardiovascular medication, which combines cilnidipine 20 mg and telmisartan 40

The Directorate General of Trade Remedies (DGTR) is currently assessing the parameters of the Product Under Consideration (PUC) and the utilization of the Product Control Numbers (PCN) approach in an ongoing investigation into allegations of anti-dumping related to siloxane polyoxyalkylene

Indoco Remedies Limited (Indoco), a fully integrated pharma enterprise with a robust global presence, announced a groundbreaking partnership with the UK-based company, Clarity Pharma. This strategic alliance represents a pivotal event for Indoco, as it plans to release approximately 20